Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Feb 01 2022

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-01-2022-12

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 01, 2022, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Clarithromycin Tablets USP, 250 mg and 500 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases